# HIV P-adic Hyperbolic Analysis Documentation

> **Comprehensive documentation for HIV-1 evolution analysis using p-adic hyperbolic geometry**

**Version:** 2.0
**Last Updated:** December 26, 2025
**Total Documents:** 27
**Total Records Analyzed:** 202,085

---

## Quick Navigation

| I want to... | Go to... |
|--------------|----------|
| Get an overview of findings | [EXECUTIVE_SUMMARY.md](00_OVERVIEW/EXECUTIVE_SUMMARY.md) |
| Understand the deep theory | [GEOMETRIC_THEORY_OF_EVOLUTION.md](00_OVERVIEW/GEOMETRIC_THEORY_OF_EVOLUTION.md) |
| Run the analysis | [QUICK_START.md](05_SUPPLEMENTARY/QUICK_START.md) |
| Understand the methodology | [METHODOLOGY.md](02_METHODOLOGY/METHODOLOGY.md) |
| See what's novel | [NOVELTY_ASSESSMENT.md](00_OVERVIEW/NOVELTY_ASSESSMENT.md) |
| Find related papers | [LITERATURE_REVIEW.md](03_REFERENCE/LITERATURE_REVIEW.md) |
| Troubleshoot issues | [FAQ.md](05_SUPPLEMENTARY/FAQ.md) |

---

## Directory Structure

```
HIV_PADIC_ANALYSIS/
│
├── 00_OVERVIEW/                    # Start here - Core documents
│   ├── EXECUTIVE_SUMMARY.md        # Complete overview for researchers
│   ├── GEOMETRIC_THEORY_OF_EVOLUTION.md  # Theoretical framework
│   ├── INDEX.md                    # Original navigation index
│   ├── NOVELTY_ASSESSMENT.md       # Novel vs. confirmed findings
│   └── STRATEGIC_FINDINGS_AND_OUTREACH.md  # Key discoveries summary
│
├── 01_FINDINGS/                    # Research results by domain
│   ├── DRUG_RESISTANCE_FINDINGS.md # 7,154 records, r=0.41 correlation
│   ├── CTL_ESCAPE_FINDINGS.md      # 2,115 epitopes, HLA escape
│   ├── ANTIBODY_NEUTRALIZATION_FINDINGS.md  # 189,879 bnAb records
│   ├── TROPISM_FINDINGS.md         # 2,932 sequences, Position 22
│   └── INTEGRATION_FINDINGS.md     # 387 vaccine targets
│
├── 02_METHODOLOGY/                 # Technical documentation
│   ├── METHODOLOGY.md              # Complete technical methods
│   ├── API_REFERENCE.md            # Python function documentation
│   ├── STATISTICAL_GUIDE.md        # Statistics interpretation
│   ├── BENCHMARKING.md             # Comparison with existing methods
│   └── SOFTWARE_ARCHITECTURE.md    # System design
│
├── 03_REFERENCE/                   # Reference materials
│   ├── LITERATURE_REVIEW.md        # 150 papers analyzed
│   ├── GLOSSARY.md                 # 100+ technical terms
│   ├── DATA_DICTIONARY.md          # Data file specifications
│   └── FIGURES_GUIDE.md            # Visualization descriptions
│
├── 04_IMPLEMENTATION/              # Development roadmap
│   ├── IMPROVEMENT_PLAN.md         # 47 improvements identified
│   ├── FUTURE_IMPLEMENTATION_ROADMAP.md  # 45 features planned
│   ├── MASTER_IMPLEMENTATION_PLAN.md     # Complete spec (75+ features)
│   └── FUTURE_DIRECTIONS.md        # 3-year research roadmap
│
└── 05_SUPPLEMENTARY/               # Getting started and support
    ├── QUICK_START.md              # 10-minute setup guide
    ├── FAQ.md                      # Common questions
    ├── REPRODUCIBILITY_GUIDE.md    # Step-by-step reproduction
    └── LIMITATIONS_AND_CAVEATS.md  # Known limitations
```

---

## Key Findings Summary

### Novel Discoveries

| Finding | Status | Significance |
|---------|--------|--------------|
| P-adic hyperbolic codon geometry | **NOVEL** | First application to HIV |
| Distance-resistance correlation (r=0.41) | **NOVEL** | New predictive relationship |
| Position 22 as top tropism determinant | **NOVEL** | Exceeds classic 11/25 rule |
| P-adic vs Hamming correlation (r=0.83) | **NOVEL** | Geometry validated |
| 387 safe vaccine targets identified | **NOVEL** | First systematic ranking |
| L63P as MDR marker (79.5%) | **NOVEL** | Clinical screening target |

### Clinical Applications (2025-12-26)

| Application | Value | Location |
|-------------|-------|----------|
| Top Vaccine Candidate | TPQDLNTML (Gag) | [INTEGRATION_FINDINGS.md](01_FINDINGS/INTEGRATION_FINDINGS.md) |
| MDR High-Risk Sequences | 2,489 (34.8%) | `results/clinical_applications/` |
| Druggable Tat Targets | 247 proteins | `results/clinical_applications/` |
| Host-Directed Targets | 449 (Tat protein) | [EXECUTIVE_SUMMARY.md](00_OVERVIEW/EXECUTIVE_SUMMARY.md) |

---

## Reading Order by Audience

### For HIV Researchers
1. [EXECUTIVE_SUMMARY.md](00_OVERVIEW/EXECUTIVE_SUMMARY.md)
2. [NOVELTY_ASSESSMENT.md](00_OVERVIEW/NOVELTY_ASSESSMENT.md)
3. Relevant findings document
4. [LITERATURE_REVIEW.md](03_REFERENCE/LITERATURE_REVIEW.md)

### For Computational Biologists
1. [METHODOLOGY.md](02_METHODOLOGY/METHODOLOGY.md)
2. [API_REFERENCE.md](02_METHODOLOGY/API_REFERENCE.md)
3. [BENCHMARKING.md](02_METHODOLOGY/BENCHMARKING.md)
4. [REPRODUCIBILITY_GUIDE.md](05_SUPPLEMENTARY/REPRODUCIBILITY_GUIDE.md)

### For Vaccine Developers
1. [EXECUTIVE_SUMMARY.md](00_OVERVIEW/EXECUTIVE_SUMMARY.md)
2. [INTEGRATION_FINDINGS.md](01_FINDINGS/INTEGRATION_FINDINGS.md)
3. [LIMITATIONS_AND_CAVEATS.md](05_SUPPLEMENTARY/LIMITATIONS_AND_CAVEATS.md)
4. [FUTURE_DIRECTIONS.md](04_IMPLEMENTATION/FUTURE_DIRECTIONS.md)

### For Quick Evaluation
1. [QUICK_START.md](05_SUPPLEMENTARY/QUICK_START.md)
2. [BENCHMARKING.md](02_METHODOLOGY/BENCHMARKING.md)
3. [FAQ.md](05_SUPPLEMENTARY/FAQ.md)

---

## Related Resources

| Resource | Location | Description |
|----------|----------|-------------|
| Clinical Applications | `results/clinical_applications/` | Decision support reports |
| Research Discoveries | `results/research_discoveries/` | Latest findings |
| Analysis Scripts | `scripts/` | `clinical_applications.py`, `research_discoveries.py` |
| HIV Results | `research/bioinformatics/codon_encoder_research/hiv/results/` | Raw analysis outputs |

---

## Data Sources

| Dataset | Records | Key Variables |
|---------|---------|---------------|
| Stanford HIVDB | 7,154 | Drug resistance fold-changes |
| LANL CTL Epitopes | 2,115 | HLA restrictions, escape mutations |
| CATNAP | 189,879 | IC50/IC80 neutralization values |
| V3 Coreceptor | 2,935 | CCR5/CXCR4 tropism labels |
| HIV-Human PPI | 4,549 | Protein-protein interactions |

**Total: 202,085 records**

---

_Last updated: December 26, 2025_
